ulrich medical grows for 15th consecutive year
Germany-based medical technology manufacturer ulrich medical and its subsidiaries in France, Spain and the USA closed the 2024 financial year with a revenue of €163 million, 10 per cent more than the previous year, which means the company has increased its revenue for the 15th consecutive year. It also recorded a 20 per cent increase in profit.
CEO and chair of the executive board Klaus Kiesel said: “Our profitable growth is the result of the realisation of long-term business strategies,” and co-CEO Friedrich von Rechteren added: “We are proving that focusing consistently on ‘made in Germany’ and being successful on an international scale are not
mutually exclusive.”
The company says it has achieved a market share of considerably more than 25 per cent in Europe, with a key driver for success being contrast media
injectors for the CT and MRI product group. To satisfy growing demand, it has rented additional production premises close to the city of Ulm.
Picture: the company’s contrast media injectors for the CT and MRI product group have been a key driver of a revenue increase.
Read this report on page 4 of the March 2025 issue of RAD Magazine.
